.Regardless of izokibep keeping its newfound winning streak in the medical clinic, Acelyrin is actua...
.Rivus Pharmaceuticals has actually plumped up the leads of its own fat-busting, muscle-sparing drug...
.Ovid Therapeutics already exposed last month that it was actually trimming its head count as the fi...
.Eli Lilly has opened a $700 million R&D facility in the Boston Port, boosting its own RNA and al...
.Simply 5 months after protecting a $100 million IPO, Limitless Bio is already laying off some staff...
.The first stages of oncology R&D may not be short of appealing brand new modalities, as well as ...
.Psychopharmacology has taken three posts concerning midstage clinical trial records determining Lyk...
.Avidity Biosciences amazed entrepreneurs with phase 1/2 records in Duchenne muscular dystrophy (DMD...
.Actinogen Medical's cortisol blocker has overlooked the main endpoint of a phase 2 study in depress...
.Antibody-drug conjugates (ADCs) have been at the center of lots of a billion-dollar biobuck licensi...